You are here

Intralesional Therapies Gain Recognition for Melanoma Treatment

Merrick Ross, chief of the melanoma section in the Department of Surgical Oncology at MD Anderson Cancer Center in Houston, discusses the promising role of intralesional therapies for melanoma. Recent research has credited these injectables with prompting both a local and systemic response in patients, who often have a high rate of distant disease.

American Society of Clinical Oncology, May/June 2014